Chapman MS, Cirulli J, McBride S. Sustained Improvement in Patient-Reported Outcomes with Continued Apremilast Treatment over 104 Weeks in Patients with Moderate to Severe Psoriasis. J of Skin [Internet]. 2018Feb.23 [cited 2024Sep.20];2(S1):S23. Available from: https://dermsquared.com/skin/article/view/267